Mednet Logo
HomeHospital Medicine
Hospital Medicine

Hospital Medicine

Physician discussions on inpatient care, transitions of care, diagnostic reasoning, and hospital-based protocols.

Recent Discussions

How do you manage HIT in a patient with high bleeding risk?

1
1 Answers

Mednet Member
Mednet Member
Hematology · University of Wisconsin

If bleeding risk associated with the administration of an alternative anticoagulant is unacceptably risky, I usually recommend the administration of IVIG. Theodore E. Warkentin, PMID 31274032

Do you routinely obtain a chest x-ray prior to initiating anti-TNF or other biologic therapy?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Johns Hopkins School of Medicine

I don't routinely order a chest x-ray in patients with negative quantiferon (or other latent TB testing such as the T-spot) before starting biologics. The chest x-ray is much less specific for latent TB, particularly in the United States where TB is not endemic. Patients may have granulomas or other...

Are you comfortable using DOACs in obese patients with VTE?

1 Answers

Mednet Member
Mednet Member
Hematology · Mayo Clinic

Although there are no direct randomized trials in this population of patients, emerging data from systematic reviews suggest that DOACs are non-inferior to warfarin in patients >120 kg. (Elshafei et al., PMID 32556939).

What is your preferred approach for patients with anti-phospholipid syndrome with recurrent thrombosis on coumadin and LMWH?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Hackensack University Medical Center

This is a difficult condition to manage and personalized approach/risk stratification is key. There are several potential considerations:Warfarin therapy could be intensified, anti-platelet agents could be considered (although not in combination with LMWH).For patients with an underlying autoimmune ...

Do you routinely check for copper deficiency as part of workup for bicytopenia with leukopenia/anemia or pancytopenia?

1
1 Answers

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · John Hopkins Medicine

I do not usually check for this but not unreasonable if there is a clinical reason to check.

In patients with high-risk polycythemia vera with a history of thrombosis, should aspirin be used in addition to indefinite anticoagulation and cytoreduction for prevention of recurrent thrombosis?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Taussig Cancer Institute

I do not continue aspirin in patients who require anticoagulation out of concern for an increased risk of bleeding. In an analysis of the REVEAL database, patients receiving anticoagulation in combination with aspirin were over 4-fold as likely to have a hemorrhage (HR [95% CI] = 4.22 [2.57, 6.94]; ...

What is your typical workup for a patient with a spontaneous renal infarct?

1 Answers

Mednet Member
Mednet Member
Hematology · Mayo Clinic

Broadly speaking, in the setting of a renal infarct, consider a thromboembolic event (venous thrombosis with paradoxical embolism or an arterial source) or a local vascular event such as dissection. The latter can be easily missed because the appropriate imaging is generally not performed. Once a va...

What workup do you recommend for patients with stabbing headaches?

1 Answers

Mednet Member
Mednet Member
Neurology · Greater Boston Headache Center at Boston Advanced Medicine

Stabbing headaches, also called icepick headaches or jabs & jolts, are severe pains in the head, often occurring spontaneously but sometimes caused by coughing or sneezing, lasting for seconds. They are so intense that they make the sufferer grab his or her head. They generally occur infrequently in...

What is your approach to a patient with normal LFTS and high titer auto-antibodies suggestive of autoimmune hepatitis?

1 Answers

Mednet Member
Mednet Member
Rheumatology · University of California, Berkeley and San Francisco

Normal LFTs in the setting of high titer liver autoantibodies would still lead me to request a Hepatology consult, even in the setting of a previously defined autoimmune disease, i.e., SLE or Sjogrens. After Hepatology assessment, and if there is a documented rheumatologic autoimmune disease, most o...

Is there any experience of using sarilumab instead of tocilizumab for steroid sparing effect in GCA during national tocilizumab shortage?

1 Answers

Mednet Member
Mednet Member
Rheumatology · University of Pittsburgh School of Medicine

This is certainly a very good question, but unfortunately, we don't have an answer. The sarilumab GCA and PMR trials were unfortunately terminated due to the pandemic. I've heard of anecdotal experiences of the use of sarilumab but haven't used it myself (not sure if insurances would approve). Both ...